Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Pazopanib Hcl

Open in the dashboard

Part D claims

1,936

Prescriptions dispensed, refills included

Drug cost

$14,186,000

Paid at the pharmacy, in all

Prescribers

123

With 11 or more claims of it

In 2024, Medicare Part D recorded 1,936 claims for Pazopanib Hcl from 123 prescribers, at a total drug cost of $14.2 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 34 states and territories
Part D claims for Pazopanib Hcl by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 20 275 $1,759,705
NY 9 149 $877,105
TX 11 140 $1,287,232
FL 9 124 $1,102,960
OH 4 121 $736,175
MO 6 97 $647,092
PA 4 88 $750,729
GA 3 83 $791,026
MI 4 75 $509,994
AL 3 66 $385,874
MN 4 53 $273,197
VA 4 53 $456,415
NM 3 49 $272,136
NC 2 47 $415,834
WA 2 43 $257,265
The other 19 states and territories
State Prescribers Claims Drug cost
CT 2 42 $266,264
NE 3 40 $315,371
LA 3 40 $396,014
MD 3 36 $335,401
SC 3 34 $267,558
IL 2 29 $226,937
OK 2 27 $219,065
KS 2 26 $245,357
KY 2 26 $188,533
IN 2 25 $181,670
CO 2 25 $183,881
AZ 2 23 $159,146
TN 1 18 $107,069
IA 1 17 $56,460
MT 1 16 $138,008
NV 1 15 $112,844
ND 1 12 $133,767
WI 1 11 $69,272
OR 1 11 $60,643

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 11 of 11
Part D claims for Pazopanib Hcl by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 67 1,043 $7,942,044
Medical Oncology 27 413 $2,804,322
Internal Medicine 10 142 $976,116
Nurse Practitioner 7 124 $873,104
Pulmonary Disease 1 64 $408,845
Physician Assistant 4 55 $434,277
Pharmacist 2 28 $143,685
Hematology 2 26 $271,949
Pediatric Medicine 1 16 $133,713
Certified Clinical Nurse Specialist 1 13 $68,074
Endocrinology 1 12 $129,871

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Joseph Parambil Pulmonary Disease OH 64 $408,845 None on record
Melissa Burgess Hematology-Oncology PA 52 $469,189 None on record
William Read Hematology-Oncology GA 36 $266,761 None on record
Robert Conry Hematology-Oncology AL 35 $172,401 None on record
Hari Deshpande Medical Oncology CT 31 $144,458 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Other names for pazopanib hcl

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record